5,7-Dihydroxy-4′-methoxyisoflavone induces apoptosis by inhibiting the ERK and Akt pathways in human osteosarcoma cells

References

• Zhu Y, Zhou J, Ji Y, Yu B. Elevated expression of AKT2 correlates with disease severity and poor prognosis in human osteosarcoma. Mol Med Rep 2014;10:737–42
   Web of Science ®Google Scholar
• Robert G, Chappé C, Taque S, Bruneau B, Gandemer V. Hearing loss during osteosarcoma chemotherapy: when acute ifosfamide toxicity revealed unnoticed methotrexate. J Pediatr Hematol Oncol 2014;36:e100–2
   Google Scholar
• Arndt CA, Rose PS, Folpe AL, Laack NN. Common musculoskeletal tumors of childhood and adolescence. Mayo Clin Proc 2012;87:475–87
   PubMed Web of Science ®Google Scholar
• May FE. Novel drugs that target the estrogen-related receptor alpha: their therapeutic potential in breast cancer. Cancer Manag Res 2014;6:225–52
   PubMed Web of Science ®Google Scholar
• Chrzan BG, Bradford PG. Phytoestrogens activate estrogen receptor beta1 and estrogenic responses in human breast and bone cancer cell lines. Mol Nutr Food Res 2007;51:171–7
   PubMed Web of Science ®Google Scholar
• Puthli A, Tiwari R, Mishra KP. 5,7-Dihydroxy-4′-methoxyisoflavone enhances the radiotoxicity in colon tumor cells in vitro. J Environ Pathol Toxicol Oncol 2013;32:189–203
   PubMed Web of Science ®Google Scholar
• Seo YJ, Kim BS, Chun SY, Park YK, Kang KS, Kwon TG. Apoptotic effects of genistein, biochanin-A and apigenin on LNCaP and PC-3 cells by p21 through transcriptional inhibition of polo-like kinase-1. J Korean Med Sci 2011;26:1489–94
   PubMed Web of Science ®Google Scholar
• Lee CH, Huang YL, Liao JF, Chiou WF. Ugonin K-stimulated osteogenesis involves estrogen receptor-dependent activation of non-classical Src signaling pathway and classical pathway. Eur J Pharmacol 2012;676:26–33
   PubMed Web of Science ®Google Scholar
• Botter SM, Neri D, Fuchs B. Recent advances in osteosarcoma. Curr Opin Pharmacol 2014;16C:15–23
   Web of Science ®Google Scholar
• Zhang C, Peng J, Wu S, Jin Y, Xia F, Wang C, Liu K, Sun H, Liu M. Dioscin promotes osteoblastic proliferation and differentiation via Lrp5 and ER pathway in mouse and human osteoblast-like cell lines. J Biomed Sci 2014;21:30
   PubMed Web of Science ®Google Scholar
• Lee CH, Huang YL, Liao JF, Chiou WF. Ugonin K-stimulated osteogenesis involves estrogen receptor-dependent activation of non-classical Src signaling pathway and classical pathway. Eur J Pharmacol 2012;676:26–33
   PubMed Web of Science ®Google Scholar
• Hwang KA, Park MA, Kang NH, Yi BR, Hyun SH, Jeung EB, Choi KC. Anticancer effect of genistein on BG-1 ovarian cancer growth induced by 17 β-estradiol or bisphenol A via the suppression of the crosstalk between estrogen receptor α and insulin-like growth factor-1 receptor signaling pathways. Toxicol Appl Pharmacol 2013;272:637–46
   PubMed Web of Science ®Google Scholar
• Thelen P, Wuttke W, Seidlová-Wuttke D. Phytoestrogens selective for the estrogen receptor beta exert anti-androgenic effects in castration resistant prostate cancer. J Steroid Biochem Mol Biol 2014;139:290–3
   PubMed Web of Science ®Google Scholar
• Collins-Burow BM, Antoon JW, Frigo DE, Elliott S, Weldon CB, Boue SM, Beckman BS, Curiel TJ, Alam J, McLachlan JA, Burow ME. Antiestrogenic activity of flavonoid phytochemicals mediated via the c-Jun N-terminal protein kinase pathway. Cell-type specific regulation of estrogen receptor alpha. J Steroid Biochem Mol Biol 2012;132:186–93
   PubMed Web of Science ®Google Scholar
• Chen J, Zhao X, Ye Y, Wang Y, Tian J. Estrogen receptor beta-mediated proliferative inhibition and apoptosis in human breast cancer by calycosin and formononetin. Cell Physiol Biochem 2013;32:1790–7
   PubMed Web of Science ®Google Scholar
• Huang WJ, Bi LY, Li ZZ, Zhang X, Ye Y. Formononetin induces the mitochondrial apoptosis pathway in prostate cancer cells via downregulation of the IGF-1/IGF-1R signaling pathway. Pharm Biol 2014;52:466–70
   Web of Science ®Google Scholar
• Zhang X, Bi L, Ye Y, Chen J. Formononetin induces apoptosis in PC-3 prostate cancer cells through enhancing the Bax/Bcl-2 ratios and regulating the p38/Akt pathway. Nutr Cancer 2014;66:656–61
   PubMed Web of Science ®Google Scholar
• Nakamura A, Aizawa J, Sakayama K, Kidani T, Takata T, Norimatsu Y, Miura H, Masuno H. Genistein inhibits cell invasion and motility by inducing cell differentiation in murine osteosarcoma cell line LM8. BMC Cell Biol 2012;13:24
   PubMed Web of Science ®Google Scholar
• Bhardwaj V, Tadinada SM, Jain A, Sehdev V, Daniels CK, Lai JC, Bhushan A. 5,7-Dihydroxy-4′-methoxyisoflavone reduces pancreatic cancer survival and progression. Anticancer Drugs 2014;25:296–302
   PubMed Web of Science ®Google Scholar
• An G, Morris ME. The sulfated conjugate of 5,7-dihydroxy-4′-methoxyisoflavone is a substrate of breast cancer resistant protein (ABCG2). Biopharm Drug Dispos 2011;32:446–57
   PubMed Web of Science ®Google Scholar
• Svoboda M, Hamilton G, Thalhammer T. Steroid hormone metabolizing enzymes in benign and malignant human bone tumors. Expert Opin Drug Metab Toxicol 2010;6:427–37
   PubMed Web of Science ®Google Scholar
• Chen J, Sun L. Formononetin-induced apoptosis by activation of Ras/p38 mitogen-activated protein kinase in estrogen receptor-positive human breast cancer cells. Horm Metab Res 2012;44:943–8
   PubMed Web of Science ®Google Scholar
• Diab S, Kumarasiri M, Yu M, Teo T, Proud C, Milne R, Wang S. MAP kinase-interacting kinases-emerging targets against cancer. Chem Biol 2014;21:441–52
   PubMed Web of Science ®Google Scholar
• Shin DY, Kim GY, Hwang HJ, Kim WJ, Choi YH. Diallyl trisulfide-induced apoptosis of bladder cancer cells is caspase-dependent and regulated by PI3K/Akt and JNK pathways. Environ Toxicol Pharmacol 2014;37:74–83
   PubMed Web of Science ®Google Scholar
• Rahmani M, Aust MM, Attkisson E, Williams DC Jr, Ferreira-Gonzalez A, Grant S. Dual inhibition of Bcl-2 and Bcl-xL strikingly enhances PI3K inhibition-induced apoptosis in human myeloid leukemia cells through a GSK3- and Bim-dependent mechanism. Cancer Res 2013;73:1340–51
   PubMed Web of Science ®Google Scholar
• Johnson TL, Lai MB, Lai JC, Bhushan A. Inhibition of cell proliferation and MAP Kinase and Akt pathways in oral squamous cell carcinoma by genistein and 5,7-dihydroxy-4′-methoxyisoflavone. Evid-Based Complement Alternat Med 2010;7:351–8
   PubMed Web of Science ®Google Scholar
• Monian P, Jiang X. Clearing the final hurdles to mitochondrial apoptosis: regulation post cytochrome C release. Exp Oncol 2012;34:185–91
   PubMedGoogle Scholar
• Martinou JC, Youle RJ. Mitochondria in apoptosis: Bcl-2 family members and mitochondrial dynamics. Dev Cell 2011;21:92–101
   PubMed Web of Science ®Google Scholar
• Soriano ME, Scorrano L. The interplay between BCL-2 family proteins and mitochondrial morphology in the regulation of apoptosis. Adv Exp Med Biol 2010;687:97–114
   PubMed Web of Science ®Google Scholar
• Vitagliano O, Addeo R, D'Angelo V, Indolfi C, Indolfi P, Casale F. The Bcl-2/Bax and Ras/Raf/MEK/ERK signaling pathways: implications in pediatric leukemia pathogenesis and new prospects for therapeutic approaches. Expert Rev Hematol 2013;6:587–97
   PubMed Web of Science ®Google Scholar